Related Experiment Video
Updated: Aug 12, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
IgG4-related disease mimicking gynecologic malignancy
Rachel R Pacyna1, Nicole A Cipriani2, Melvy S Mathew3
1Pritzker School of Medicine, The University of Chicago, 5841 S Maryland Ave, Chicago, IL 60637, USA.
Immunoglobulin G4 (IgG4) related disease can mimic gynecologic cancer, presenting as masses and lymphadenopathy. Early diagnosis is key for appropriate treatment with steroids or rituximab, distinguishing it from actual malignancies.
Area of Science:
- Gynecologic Oncology
- Immunology
- Pathology
Background:
- Immunoglobulin G4 (IgG4) related disease is a systemic condition characterized by fibrosis and IgG4-positive plasma cell infiltration.
- Gynecologic organ involvement is rare, making diagnosis challenging.
- Distinguishing IgG4-related disease from malignancy is critical due to differing treatment protocols.
Observation:
- Two cases of IgG4-related disease presenting as gynecologic malignancy mimics are described.
- Case 1: An 85-year-old woman with a uterine mass and lymphadenopathy, initially concerning for malignancy.
- Case 2: A 35-year-old woman with FDG-avid lymphadenopathy mimicking cervical cancer recurrence.
Findings:
- Biopsies in Case 1 revealed IgG4-positive plasma cells, leading to rituximab treatment.
- Biopsies in Case 2 showed lymphoid hyperplasia with increased IgG4 plasma cells, not carcinoma, after extensive workup.
- Both patients showed improvement with appropriate IgG4-related disease treatment (rituximab or steroids).
Implications:
- IgG4-related disease should be considered in the differential diagnosis of primary or recurrent gynecologic malignancies.
- Positron emission tomography (PET) imaging can reveal FDG-avid lesions in IgG4-related disease, mimicking cancer.
- Accurate diagnosis of IgG4-related disease is essential for effective treatment and avoiding unnecessary oncologic interventions.
More Related Videos
10:21A Coregistered Ultrasound and Photoacoustic Imaging Protocol for the Transvaginal Imaging of Ovarian Lesions
Published on: March 3, 2023
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024